Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |